BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 31842565)

  • 41. Implementation of next-generation sequencing for molecular diagnosis of hereditary breast and ovarian cancer highlights its genetic heterogeneity.
    Pinto P; Paulo P; Santos C; Rocha P; Pinto C; Veiga I; Pinheiro M; Peixoto A; Teixeira MR
    Breast Cancer Res Treat; 2016 Sep; 159(2):245-56. PubMed ID: 27553368
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Uncommon EGFR Mutations in Non-Small Cell Lung Cancer and Their Impact on the Treatment.
    Bílek O; Holánek M; Berkovcová J; Horký O; Kazda T; Čoupková H; Špelda S; Kristková L; Zvaríková M; Podhorec J; Bořilová S; Bohovicová L; Zdražilová Dubská L
    Klin Onkol; 2019; 32(Supplementum 3):6-12. PubMed ID: 31627700
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Current FIGO Staging for Carcinoma of the Cervix Uteri and Treatment of Particular Stages.
    Sehnal B; Kmoníčková E; Sláma J; Tomancová V; Zikán M
    Klin Onkol; 2019; 32(3):224-231. PubMed ID: 31216857
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Small cell carcinoma of the uterine cervix: a case report and literature review.
    Silva-Meléndez PE; Escobar PF; Héctor Silva ; Gutiérrez S; Rodríguez M
    Bol Asoc Med P R; 2015; 107(1):55-7. PubMed ID: 26035987
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Germline genetic variants in men with prostate cancer and one or more additional cancers.
    Pilié PG; Johnson AM; Hanson KL; Dayno ME; Kapron AL; Stoffel EM; Cooney KA
    Cancer; 2017 Oct; 123(20):3925-3932. PubMed ID: 28657667
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A high frequency of PALB2 mutations in Jamaican patients with breast cancer.
    Lerner-Ellis J; Donenberg T; Ahmed H; George S; Wharfe G; Chin S; Lowe D; Royer R; Zhang S; Narod S; Hurley J; Akbari MR
    Breast Cancer Res Treat; 2017 Apr; 162(3):591-596. PubMed ID: 28194609
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The spectrum of genetic variants in hereditary pancreatic cancer includes Fanconi anemia genes.
    Slavin TP; Neuhausen SL; Nehoray B; Niell-Swiller M; Solomon I; Rybak C; Blazer K; Adamson A; Yang K; Sand S; Guerrero-Llamas N; Castillo D; Herzog J; Wu X; Tao S; Raja S; Chung V; Singh G; Nadesan S; Brown S; Cruz-Correa M; Petersen GM; Weitzel J;
    Fam Cancer; 2018 Apr; 17(2):235-245. PubMed ID: 28687971
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Detection of EGFR Mutations in Circulating Tumor DNA (ctDNA) Retrieved from Plasma - Interlaboratory Quality Assessment in the Czech Republic.
    Linda Č; Markéta K; Ivana T; Eva P; Milada M; Hana V; Ondřej H; Karolína B; Jiří D; Monika B; Pavel D
    Klin Onkol; 2018; 31(5):353-360. PubMed ID: 30541321
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Non-Small Cell Lung Cancer with Estrogen Receptors and ALK Positivity.
    Žarnayová L; Kolek V; Bouchal J; Ehrmann J
    Klin Onkol; 2018; 31(6):457-460. PubMed ID: 31035769
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Large cell variant of small cell carcinoma, hypercalcemic type, of primary peritoneal origin.
    Popiolek DA; Kumar AR; Mittal K
    Gynecol Oncol; 2005 Jan; 96(1):249-53. PubMed ID: 15589611
    [TBL] [Abstract][Full Text] [Related]  

  • 51. DICER1 Syndrome.
    Hořínová V; Drábová K; Nosková H; Bajčiová V; Šoukalová J; Černá L; Hůrková V; Slabý O; Štěrba J
    Klin Onkol; 2019; 32(Supplementum2):123-127. PubMed ID: 31409088
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Small cell neuroendocrine carcinomas of the uterine cervix: a histological, immunohistochemical, and molecular genetic study.
    Ishida GM; Kato N; Hayasaka T; Saito M; Kobayashi H; Katayama Y; Sasou S; Yaegashi N; Kurachi H; Motoyama T
    Int J Gynecol Pathol; 2004 Oct; 23(4):366-72. PubMed ID: 15381906
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Association of Li-Fraumeni Syndrome With Small Cell Carcinoma of the Ovary, Hypercalcemic Type and Concurrent Pleomorphic Liposarcoma of the Cervix.
    Tandon B; Hagemann IS; Maluf HM; Pfeifer JD; Al-Kateb H
    Int J Gynecol Pathol; 2017 Nov; 36(6):593-599. PubMed ID: 28177947
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Stereotactic Body Radiotherapy - Current Indications.
    Burkoň P; Slavik M; Kazda T; Pospíšil P; Prochazka T; Vrzal M; Šlampa P
    Klin Onkol; 2019; 32(1):10-24. PubMed ID: 30894002
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Oncopathological aspects of BRCA1 and BRCA2 genes inactivation in tumors of ovary, fallopian tube and pelvic peritoneum].
    Škapa P; Dundr P
    Cesk Patol; 2016; 52(4):199-204. PubMed ID: 27869446
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Breast Cancer in BRCA1/2 Mutation Carriers - Do We Treat It Differently? Focus on Systemic Therapy for BRCA1/2 Associated Breast Cancer.
    Palácová M
    Klin Onkol; 2019; 32(Supplementum2):24-30. PubMed ID: 31409078
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Possible Usage of p63 in Bioptic Diagnostics.
    Galoczová M; Nenutil R; Coates P; Vojtěšek B
    Klin Onkol; 2018; 31(Suppl 2):27-31. PubMed ID: 31023021
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [PALB2 as Another Candidate Gene for Genetic Testing in Patients with Hereditary Breast Cancer in Czech Republic].
    Janatová M; Borecká M; Soukupová J; Kleiblová P; Stříbrná J; Vočka M; Zemánková P; Panczak A; Veselá K; Souček P; Foretová L; Kleibl Z
    Klin Onkol; 2016; 29 Suppl 1():S31-4. PubMed ID: 26691940
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Plasma Cell Leukemia –  the Forgotten Dis­ease.
    Žárska M; Vrábel D; Bezdekova R; Štork M; Jarošová M; Adam Z; Krejčí M; Pour L; Ševčíková S
    Klin Onkol; 2019; 32(1):40-46. PubMed ID: 30764628
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Small cell cancers of the female genital tract: Molecular and clinical aspects.
    Patibandla JR; Fehniger JE; Levine DA; Jelinic P
    Gynecol Oncol; 2018 May; 149(2):420-427. PubMed ID: 29458976
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.